14673877|t|Role of dopamine transporter imaging in routine clinical practice.
14673877|a|Functional imaging of the dopamine transporter (DAT) defines integrity of the dopaminergic system and has its main clinical application in patients with mild, incomplete, or uncertain parkinsonism. Imaging with specific single positron emission computerised tomography ligands for DAT (FP-CIT, beta-CIT, IPT, TRODAT) provides a marker for presynaptic neuronal degeneration. Striatal uptake correlates with disease severity, in particular bradykinesia and rigidity, and monitoring of progression assists in clinical trials of potential neuroprotective drugs. DAT imaging is abnormal in idiopathic Parkinson's disease, multiple system atrophy and progressive supranuclear palsy and does not distinguish between these disorders. Dopamine loss is seen even in the earliest clinical presentations of true parkinsonism; a normal scan suggests an alternative diagnosis such as essential tremor, vascular parkinsonism (unless there is focal basal ganglia infarction), drug-induced parkinsonism, or psychogenic parkinsonism. Congruence between working clinical diagnosis and DAT imaging increases over time in favour of baseline DAT imaging results. Additional applications are characterising dementia with parkinsonian features (abnormal results in dementia with Lewy bodies, normal in Alzheimer's disease); and differentiating juvenile-onset Parkinson's disease (abnormal DAT) from dopa-responsive dystonia (normal DAT).
14673877	8	28	dopamine transporter	Gene	6531
14673877	93	113	dopamine transporter	Gene	6531
14673877	115	118	DAT	Gene	6531
14673877	206	214	patients	Species	9606
14673877	251	263	parkinsonism	Disease	MESH:D010302
14673877	348	351	DAT	Gene	6531
14673877	353	359	FP-CIT	Chemical	MESH:C087552
14673877	361	369	beta-CIT	Chemical	MESH:C069723
14673877	371	374	IPT	Chemical	-
14673877	376	382	TRODAT	Chemical	-
14673877	418	439	neuronal degeneration	Disease	MESH:D009410
14673877	505	517	bradykinesia	Disease	MESH:D018476
14673877	522	530	rigidity	Disease	MESH:D009127
14673877	625	628	DAT	Gene	6531
14673877	652	682	idiopathic Parkinson's disease	Disease	MESH:D010300
14673877	684	707	multiple system atrophy	Disease	MESH:D019578
14673877	712	742	progressive supranuclear palsy	Disease	MESH:D013494
14673877	793	801	Dopamine	Chemical	MESH:D004298
14673877	867	879	parkinsonism	Disease	MESH:D010302
14673877	937	953	essential tremor	Disease	MESH:D020329
14673877	955	976	vascular parkinsonism	Disease	MESH:D010302
14673877	1000	1024	basal ganglia infarction	Disease	MESH:D007238
14673877	1040	1052	parkinsonism	Disease	MESH:D010302
14673877	1057	1081	psychogenic parkinsonism	Disease	MESH:D010302
14673877	1133	1136	DAT	Gene	6531
14673877	1187	1190	DAT	Gene	6531
14673877	1251	1259	dementia	Disease	MESH:D003704
14673877	1265	1277	parkinsonian	Disease	MESH:D010300
14673877	1308	1333	dementia with Lewy bodies	Disease	MESH:D020961
14673877	1345	1364	Alzheimer's disease	Disease	MESH:D000544
14673877	1402	1421	Parkinson's disease	Disease	MESH:D010300
14673877	1432	1435	DAT	Gene	6531
14673877	1442	1466	dopa-responsive dystonia	Disease	MESH:C538007
14673877	1475	1478	DAT	Gene	6531
14673877	Association	MESH:D004298	MESH:D010302
14673877	Association	MESH:C087552	MESH:D009410
14673877	Association	MESH:C069723	MESH:D009410
14673877	Association	MESH:C538007	6531
14673877	Association	MESH:D009410	6531
14673877	Association	MESH:D010302	6531
14673877	Association	MESH:D019578	6531
14673877	Association	MESH:D013494	6531
14673877	Association	MESH:D020961	6531
14673877	Association	MESH:D018476	6531
14673877	Negative_Correlation	MESH:C087552	6531
14673877	Association	MESH:D010300	6531

